This page is not the official website. Generated by AI, does not constitute any advice. If needed, please click here to visit the corresponding official website.

Eaglech (Shanghai)
Pharmaceutical Co., Ltd.

A leading pharmaceutical innovation hub based in Zhangjiang High-Tech Park, Shanghai, dedicated to R&D, production, and global supply of high-purity active pharmaceutical ingredients and key intermediates.

About Eaglech

A modern pharmaceutical high-tech enterprise integrating research, development, production, sales, and service.

Company Introduction

Eaglech (Shanghai) Pharmaceutical Co., Ltd. is located in Zhangjiang High-Tech Park, Shanghai — known as the "world's factory" for innovation. We are a modern pharmaceutical high-tech enterprise integrating R&D, production, sales, and service, with a strong focus on innovative drug development and large-scale cooperative production of generic drugs.

The company maintains strategic partnerships with leading research institutes and high-end laboratories globally, accelerating drug development and expanding our project pipeline. We have successfully launched new technologies and products in anesthesia, eye drops, anti-coagulation, and anti-allergy intermediates, establishing a clear competitive advantage in the global market.

GMP-Compliant Production Facilities
Global Distribution Network
Industry-Academia-Research Collaboration
Eaglech Pharmaceutical Research Lab

Technology & Development

Pioneering advancements in chiral synthesis, chemical drug development, and analytical technologies.

Chiral Drug Synthesis

Our expertise includes chromatographic resolution, chemical resolution, induced crystallization, membrane separation, chiral source synthesis, and chiral catalysis methods. We leverage enzyme catalysis and continuous flow technology for high-efficiency production.

Key Platforms: Enzyme Catalysis, Continuous Flow, Separation & Preparation

Chiral Drug Analysis

We utilize advanced analytical techniques including high-performance liquid chromatography (HPLC), capillary electrophoresis, molecular imprinting, supercritical fluid chromatography, and biological enzymatic methods to ensure product purity and consistency.

Techniques: HPLC, CE, SFC, Enzymatic Assays

Chemical Drug Technology Development

Our chemical medicine technology platform includes dedicated medicinal chemistry and API analysis labs. We support bulk medicine and intermediate projects for pharmaceutical manufacturers worldwide.

Facilities: API Analysis Rooms, Medicinal Chemistry Labs, GMP Workshops

Development History

2004/03

Ningbo Free Trade Zone Yuanfang Biochemicals Co., Ltd. established

2007/04

Shanghai Huishen Chemicals Co., Ltd. founded

2009/05

Ningbo Distant Chemicals Co., Ltd. launched

2021/06

Chiral Drug Synthesis Platform developed

2021/07

Advanced Chiral Drug Analysis capabilities implemented

2021/08

Chemical Drug Technology Platform expanded

2021/11

Eaglech (Shanghai) Pharmaceutical Co., Ltd. officially established

Our Products

High-purity active pharmaceutical ingredients and key intermediates for global pharmaceutical applications.

API Product

tert-Butyl [(1R,2S,5S)-2-amino-5-[(dimethylamino)carbonyl]cyclohexyl]carbamate oxalate

High-purity chiral intermediate for CNS and metabolic drug development.

Intermediate

tert-Butyl [(1R,2S,5S)-2-amino-5-[(dimethylamino)carbonyl]cyclohexyl]carbamate

Key building block for peptide-based therapeutics and enzyme inhibitors.

Chemical Compound

5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridine-2-carboxylic acid, hydrochloride

Heterocyclic intermediate with applications in kinase inhibitor synthesis.

API

Tert-Butyl(1R,2S,5S)-2-azido-5-[(dimethylamino)carbonyl]cyclohexylcarbamate oxalic acid

Azide-functionalized intermediate for click chemistry and bioconjugation.

Intermediate

4-Hydroxy-1-methyl-7-phenoxy-3-isoquinolinecarboxylic acid methyl ester

Advanced intermediate for anti-inflammatory and anti-cancer agents.

Lab Compound

(1S,3R,4R)-3-(Boc-amino)-4-hydroxy-cyclohexanecarboxylic acid ethyl ester

Chiral synthon for protease inhibitors and antiviral drug development.

Molecular Structure

Chiral Anesthesia Intermediates

Specialized compounds for next-generation anesthetic agents.

Molecular Structure

Anti-Coagulation API Intermediates

High-purity intermediates for anticoagulant drug synthesis.

Molecular Structure

Ophthalmic Drug Precursors

Specialty chemicals for eye drop formulations and ocular therapies.

Molecular Structure

Anti-Allergy Intermediate Series

Building blocks for histamine receptor antagonists and immunomodulators.

Get in Touch

For inquiries, collaborations, or technical support, please visit our official website.

Contact Information

Phone: +86 021-60290089

Email: [email protected]

Alternate Email: [email protected]

Location: Zhangjiang High Tech Park, Shanghai, China

Visit Official Website

Notice for Buyers: If you are a buyer, the above information is generated by AI collection and does not constitute any advice. If necessary, please visit the corresponding official website.

For Domain Owners: If you are the domain owner and do not want to be included by fobcompany.info, please contact [email protected] via your corporate email to cancel. We will cancel your inclusion within 3 business days.

如果您是域名所有者 不想被fobcompany.info收录 请用企业邮箱联系[email protected] 取消收录 我们将在3个工作日取消您的收录

Service Request: If you are other domain and want to be included, please contact [email protected]

如果您是其他域名合作 也请联系[email protected]